These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6286102)

  • 1. Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens.
    Lee TH; Essex M; de Noronha F; Azocar J
    Cancer Res; 1982 Oct; 42(10):3995-9. PubMed ID: 6286102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural immunity in cats to feline leukemia viral antigens.
    Ruscetti SK; Parks WP
    J Immunol; 1976 Nov; 117(5 Pt.2):2029-35. PubMed ID: 186536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to leukemia virus and tumor-associated antigens in cats.
    Essex M; Sliski A; Hardy WD; Cotter SM
    Cancer Res; 1976 Feb; 36(2 pt 2):640-5. PubMed ID: 56224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 7. Retroviral-associated eosinophilic leukemia in the cat.
    Lewis MG; Kociba GJ; Rojko JL; Stiff MI; Haberman AB; Velicer LF; Olsen RG
    Am J Vet Res; 1985 May; 46(5):1066-70. PubMed ID: 2988377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody.
    Grant CK; Michalek MT
    Int J Cancer; 1981 Aug; 28(2):209-17. PubMed ID: 6172390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a feline leukemia viral cell membrane antigen reactive with feline sera.
    Ruscetti SK; Parks WP
    J Immunol; 1977 Dec; 119(6):2194-202. PubMed ID: 72119
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of humoral immunity tests in FeLV infected cats.
    Charreyre CE; Pedersen N
    Dev Biol Stand; 1990; 72():197-200. PubMed ID: 2178116
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of suppressor cells in feline leukemia virus-associated immunosuppression.
    Langweiler M; Cockerell GL; deNoronha F
    Cancer Res; 1983 May; 43(5):1957-60. PubMed ID: 6299534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed-immunoglobulin rosette technique for detection of antibody to feline oncornavirus-associated cell membrane antigen.
    Mackey L; Jarrett W; Wilson L
    Cancer Res; 1975 Apr; 35(4):1064-8. PubMed ID: 163696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
    Lizonová A; Grófová M
    Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus.
    Lutz H; Pedersen N; Higgins J; Hübscher U; Troy FA; Theilen GH
    Cancer Res; 1980 Oct; 40(10):3642-51. PubMed ID: 6254637
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of feline leukemia virus-infected and normal cat T-cell lines in interleukin 2-conditioned medium.
    Grant CK; Ernisse BJ; Pontefract R
    Cancer Res; 1984 Feb; 44(2):498-502. PubMed ID: 6318972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of complement-dependent lytic antibodies in sera from feline leukemia virus-infected cats by the chromium-51 release assay.
    Grant CK; Worley MB; DeBoer DJ
    J Natl Cancer Inst; 1977 Jan; 58(1):157-61. PubMed ID: 189040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
    Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and tumor antibody levels in cats, and changes associated with natural feline leukemia virus infection and malignant disease.
    Grant CK; Pickard DK; Ramaika C; Madewell BR; Essex M
    Cancer Res; 1979 Jan; 39(1):75-81. PubMed ID: 216484
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus.
    de Noronha F; Schäfer W; Essex M; Bolognesi DP
    Virology; 1978 Apr; 85(2):617-21. PubMed ID: 208242
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats.
    Kitchen LW; Cotter SM
    J Clin Lab Immunol; 1988 Feb; 25(2):101-3. PubMed ID: 2836593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.